UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GLBR
951
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $5.97M | 0.01% |
39,908
-4,260
| -10% | -$612K |
|
|
RPAI
952
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $5.92M | 0.01% |
385,229
+86,084
| +29% | +$1.26M |
|
953
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
| $5.92M | 0.01% |
111,813
+1,700
| +2% | +$88.8K |
|
|
VIRX
954
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $5.9M | 0.01% |
4,310
+519
| +14% | +$602K |
|
|
RDC
955
DELISTED
Rowan Companies Plc
RDC
| $5.9M | 0.01% |
184,828
-225,755
| -55% | -$7.07M |
|
|
MACK
956
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $5.87M | 0.01% |
102,315
| – | – |
|
|
HME
957
DELISTED
HOME PROPERTIES, INC
HME
| $5.82M | 0.01% |
91,032
+2,000
| +2% | +$123K |
|
|
BEL
958
DELISTED
Belmond Ltd.
BEL
| $5.82M | 0.01% |
399,997
| – | – |
|
959
Santander
BSBR
$42.8B
| $5.79M | 0.01% |
873,850
-154,512
| -15% | -$960K |
|
|
HBI
960
DELISTED
Hanesbrands
HBI
| $5.78M | 0.01% |
234,900
-94,852
| -29% | -$1.96M |
|
961
Compañía de Minas Buenaventura
BVN
$8.11B
| $5.76M | 0.01% |
487,852
+40,800
| +9% | +$468K |
|
|
FNSR
962
DELISTED
Finisar Corp
FNSR
| $5.76M | 0.01% |
291,482
-38,568
| -12% | -$927K |
|
963
Melco Resorts & Entertainment
MLCO
$2.17B
| $5.74M | 0.01% |
160,800
-1,570,720
| -91% | -$54.3M |
|
|
WPX
964
DELISTED
WPX Energy, Inc.
WPX
| $5.72M | 0.01% |
239,320
-5,500
| -2% | -$117K |
|
|
RVBD
965
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $5.66M | 0.01% |
274,301
+1,700
| +0.6% | +$33.6K |
|
|
SGEN
966
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.64M | 0.01% |
147,568
-7,595
| -5% | -$287K |
|
967
Lloyds Banking Group
LYG
$90.9B
| $5.64M | 0.01% |
+1,096,991
| New | +$5.69M |
|
|
TRQ
968
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $5.64M | 0.01% |
168,193
+78
| +0% | +$2.89K |
|
|
KEYW
969
DELISTED
The KEYW Holding Corporation
KEYW
| $5.63M | 0.01% |
447,880
+23,208
| +5% | +$289K |
|
970
Barclays
BCS
$94.8B
| $5.61M | 0.01% |
414,668
+30,877
| +8% | +$468K |
|
971
Huntington Ingalls Industries
HII
$12.8B
| $5.58M | 0.01% |
59,007
+1,630
| +3% | +$163K |
|
972
Fortune Brands Innovations
FBIN
$6.39B
| $5.53M | 0.01% |
162,074
-2,106
| -1% | -$72.3K |
|
973
Suncor Energy
SU
$76.2B
| $5.52M | 0.01% |
129,528
+11,115
| +9% | +$433K |
|
974
Arthur J. Gallagher & Co
AJG
$63B
| $5.49M | 0.01% |
117,862
+11,900
| +11% | +$542K |
|
|
DGI
975
DELISTED
DigitalGlobe Inc.
DGI
| $5.37M | 0.01% |
193,195
+1,100
| +0.6% | +$32.9K |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.